About Technology Issues FAQ

Links

Official Page

Sorafenib for Patients with Advanced Angiosarcoma: A Phase II Trial from the French Sarcoma Group (GSF/GETO)

Sorafenib for Patients with Advanced Angiosarcoma: A Phase II Trial from the French Sarcoma Group (GSF/GETO) — Distribution of the number of citations over years.

site/software © exaly; All materials licenced under CC by-SA.